Vikram Thermo India [VIKRAMTH] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison

Vikram Thermo India

Sun Pharmaceutical
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Vikram Thermo India wins in 10 metrics, Sun Pharmaceutical wins in 10 metrics, with 0 ties. Both stocks appear equally matched on key metrics.
View Metrics Details
Vital Metrics Comparison
Metric | Vikram Thermo India | Sun Pharmaceutical | Better |
---|---|---|---|
P/E Ratio (TTM) | 15.84 | 37.73 | Vikram Thermo India |
Price-to-Book Ratio | 4.30 | 5.42 | Vikram Thermo India |
Debt-to-Equity Ratio | 5.27 | 3.26 | Sun Pharmaceutical |
PEG Ratio | -0.11 | -1.94 | Sun Pharmaceutical |
EV/EBITDA | 11.95 | 23.98 | Vikram Thermo India |
Profit Margin (TTM) | 25.77% | 19.29% | Vikram Thermo India |
Operating Margin (TTM) | 37.09% | 24.34% | Vikram Thermo India |
EBITDA Margin (TTM) | 37.09% | 24.34% | Vikram Thermo India |
Return on Equity | 6.67% | 15.08% | Sun Pharmaceutical |
Return on Assets (TTM) | 5.55% | 11.87% | Sun Pharmaceutical |
Free Cash Flow (TTM) | $-171.83M | $119.44B | Sun Pharmaceutical |
Dividend Yield | 1.03% | 1.26% | Sun Pharmaceutical |
1-Year Return | -3.14% | -14.60% | Vikram Thermo India |
Price-to-Sales Ratio (TTM) | 4.22 | 7.28 | Vikram Thermo India |
Enterprise Value | $5.29B | $3,678.87B | Sun Pharmaceutical |
EV/Revenue Ratio | 4.28 | 6.84 | Vikram Thermo India |
Gross Profit Margin (TTM) | 66.18% | 79.58% | Sun Pharmaceutical |
Revenue per Share (TTM) | $39 | $224 | Sun Pharmaceutical |
Earnings per Share (Diluted) | $10.52 | $43.23 | Sun Pharmaceutical |
Beta (Stock Volatility) | -0.32 | 0.28 | Vikram Thermo India |
Vikram Thermo India vs Sun Pharmaceutical Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Vikram Thermo India | -0.87% | 2.36% | 1.85% | 7.10% | -7.19% | -5.44% |
Sun Pharmaceutical | -0.31% | 2.80% | 3.33% | -2.89% | -7.84% | -13.69% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Vikram Thermo India | -3.14% | 205.27% | -16.57% | 140.57% | 551.48% | 307.27% |
Sun Pharmaceutical | -14.60% | 70.78% | 218.03% | 80.00% | 690.16% | 2,608.73% |
News Based Sentiment: Vikram Thermo India vs Sun Pharmaceutical
Vikram Thermo India
News based Sentiment: MIXED
September presented a mixed bag for Vikram Thermo, with a notable profit turnaround offsetting a revenue decline. The AGM and subsequent management changes, coupled with shifts in shareholding, add complexity to the investment picture. While the company's financial health appears strong, the fluctuating share price and evolving leadership warrant careful monitoring.
Sun Pharmaceutical
News based Sentiment: MIXED
October was a mixed month for Sun Pharma, with a significant acquisition balanced against a decline in net profit. Positive analyst ratings and tariff news provide offsetting positive signals, making it a month of notable, but not overwhelmingly positive, developments for investors.
Performance & Financial Health Analysis: Vikram Thermo India vs Sun Pharmaceutical
Metric | VIKRAMTH | SUNPHARMA |
---|---|---|
Market Information | ||
Market Cap | ₹5.35B | ₹4.01T |
Market Cap Category | Small cap | Large cap |
10 Day Avg. Volume | 6,814 | 3,168,435 |
90 Day Avg. Volume | 11,424 | 2,778,768 |
Last Close | ₹165.15 | ₹1,631.20 |
52 Week Range | ₹126.85 - ₹216.45 | ₹1,548.00 - ₹1,952.25 |
% from 52W High | -23.70% | -16.45% |
All-Time High | ₹311.00 (Apr 25, 2022) | ₹1,960.35 (Sep 30, 2024) |
% from All-Time High | -46.90% | -16.79% |
Growth Metrics | ||
Quarterly Revenue Growth | -0.08% | 0.10% |
Quarterly Earnings Growth | -0.08% | -0.20% |
Financial Health | ||
Profit Margin (TTM) | 0.26% | 0.19% |
Operating Margin (TTM) | 0.37% | 0.24% |
Return on Equity (TTM) | 0.07% | 0.15% |
Debt to Equity (MRQ) | 5.27 | 3.26 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹38.75 | ₹300.99 |
Cash per Share (MRQ) | ₹0.17 | ₹108.88 |
Operating Cash Flow (TTM) | ₹325.14M | ₹110.84B |
Levered Free Cash Flow (TTM) | ₹80.99M | ₹109.29B |
Dividends | ||
Last 12-Month Dividend Yield | 1.03% | 1.26% |
Last 12-Month Dividend | ₹1.75 | ₹21.00 |
Valuation & Enterprise Metrics Analysis: Vikram Thermo India vs Sun Pharmaceutical
Metric | VIKRAMTH | SUNPHARMA |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 15.84 | 37.73 |
Forward P/E | N/A | 49.91 |
PEG Ratio | -0.11 | -1.94 |
Price to Sales (TTM) | 4.22 | 7.28 |
Price to Book (MRQ) | 4.30 | 5.42 |
Market Capitalization | ||
Market Capitalization | ₹5.35B | ₹4.01T |
Enterprise Value | ₹5.29B | ₹3.68T |
Enterprise Value Metrics | ||
Enterprise to Revenue | 4.28 | 6.84 |
Enterprise to EBITDA | 11.95 | 23.98 |
Risk & Other Metrics | ||
Beta | -0.32 | 0.28 |
Book Value per Share (MRQ) | ₹38.75 | ₹300.99 |
Financial Statements Comparison: Vikram Thermo India vs Sun Pharmaceutical
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | VIKRAMTH | SUNPHARMA |
---|---|---|
Revenue/Sales | ₹286.05M | ₹137.86B |
Cost of Goods Sold | ₹96.75M | ₹28.15B |
Gross Profit | ₹189.30M | ₹109.71B |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹106.08M | ₹33.72B |
EBITDA | ₹114.82M | ₹47.66B |
Pre-Tax Income | ₹106.57M | ₹31.73B |
Income Tax | ₹27.15M | ₹8.70B |
Net Income (Profit) | ₹79.41M | ₹22.93B |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | VIKRAMTH | SUNPHARMA |
---|---|---|
Cash & Equivalents | ₹1.62M | ₹102.69B |
Total Current Assets | ₹627.63M | ₹526.24B |
Total Current Liabilities | ₹200.68M | ₹181.94B |
Long-Term Debt | ₹21.88M | ₹3.58B |
Total Shareholders Equity | ₹1.21B | ₹724.86B |
Retained Earnings | ₹806.21M | ₹578.62B |
Property, Plant & Equipment | ₹27.49M | ₹100.36B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | VIKRAMTH | SUNPHARMA |
---|---|---|
Operating Cash Flow | N/A | N/A |
Capital Expenditures | N/A | N/A |
Free Cash Flow | N/A | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | VIKRAMTH | SUNPHARMA |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 6,814 | 3,168,435 |
Average Daily Volume (90 Day) | 11,424 | 2,778,768 |
Shares Outstanding | 31.36M | 2.40B |
Float Shares | 9.25M | 1.06B |
% Held by Insiders | 0.68% | 0.56% |
% Held by Institutions | 0.00% | 0.25% |
Dividend Analysis & Yield Comparison: Vikram Thermo India vs Sun Pharmaceutical
Metric | VIKRAMTH | SUNPHARMA |
---|---|---|
Last 12-Month Dividend | ₹1.75 | ₹21.00 |
Last 12-Month Dividend Yield | 1.03% | 1.26% |
3-Year Avg Annual Dividend | ₹0.75 | ₹14.67 |
3-Year Avg Dividend Yield | 0.50% | 0.46% |
3-Year Total Dividends | ₹2.25 | ₹44.00 |
Ex-Dividend Date | Sep 19, 2025 | Jul 07, 2025 |